P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS

• Sylvain Garciaz,
• Pierre Bories,
• Leonor Lopez Almeida,
• Jean-Marie Boher,
• Coralie Belanger,
• Christian Recher,
• Olivier Hermine,
• Norbert Vey,
• Pierre Launay

Affiliations

Sylvain Garciaz

1 Institut Paoli-Calmettes, Deparment of Hematology, MARSEILLE, France

Pierre Bories

2 Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Deparment of Hematology, Toulouse, France

Leonor Lopez Almeida

3 Institut Paoli-Calmettes, Department of Clinical Research and Innovation, MARSEILLE, France

Jean-Marie Boher

3 Institut Paoli-Calmettes, Department of Clinical Research and Innovation, MARSEILLE, France

Coralie Belanger

4 Inatherys, Evry, France

Christian Recher

2 Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Deparment of Hematology, Toulouse, France

Olivier Hermine

4 Inatherys, Evry, France

Norbert Vey

3 Institut Paoli-Calmettes, Department of Clinical Research and Innovation, MARSEILLE, France

Pierre Launay

4 Inatherys, Evry, France